Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Science

New miniature scanner could revolutionise diagnosis of diseases like cancer, diabetes and arthritis

by admin September 30, 2024
September 30, 2024
New miniature scanner could revolutionise diagnosis of diseases like cancer, diabetes and arthritis

A breakthrough in miniaturising a type of scanner that uses laser light, rather than harmful X-rays, to see beneath our skin in unprecedented detail may help revolutionise medical imaging, according to a team of researchers in the UK.

The device, developed by scientists at University College London (UCL), is particularly effective at imaging blood vessels, making it a fundamentally new tool for diagnosing and managing diseases like arthritis, diabetes and some cancers.

It uses a technique called Photoaccoustic Tomography (PAT) that uses laser light, and the ultrasound waves it triggers in certain tissues, to piece together a three-dimensional image of our biology in real-time.

The technique was pioneered more than 20 years ago, but previous versions required several seconds or minutes to record an image.

The team at UCL have reduced that time to a second or less.

They hope their breakthrough will lead to a hand-held scanner for routine use in clinics that avoids the use of harmful X-rays or multi-million pound imaging tools like MRI.

“These technical advances make the system suitable for clinical use for the first time, allowing us to look at aspects of human biology and disease that we haven’t been able to before,” said Professor Paul Beard, a medical physicist at UCL who contributed to the research.

The speed at which the scanner can take images allows the device to see processes like blood-flow in real time.

“This speed avoids motion-induced blurring, providing highly-detailed images of a quality that no other scanner can provide,” said Prof Beard.

“It also means that rather than taking five minutes or longer, images can be acquired in real time, making it possible to visualise dynamic physiological events.”

A trial of the scanner involving patients with early-stage diabetes revealed new insights about low blood flow to their feet – one of the most painful and hard to treat aspects of the condition.

“Until now we haven’t been able to see exactly what is happening to cause this damage or characterise how it develops,” said Andrew Plumb, one of the study authors and associate professor of medical imaging at UCL.

“In one of our patients, we could see smooth, uniform vessels in the left foot and deformed, squiggly vessels in the same region of the right foot, indicative of problems that may lead to tissue damage in future.”

The hope is a PAT-scanner could also improve the diagnosis and treatment cancer.

Cancer tumours often have a high density of small blood vessels that don’t show up well using other imaging techniques.

“Photoacoustic imaging could be used to help cancer surgeons better distinguish tumour tissue from normal tissue by visualising the blood vessels in the tumour, helping to ensure all of the tumour is removed during surgery and minimising the risk of recurrence,” said Dr Nam Huynh from UCL Medical Physics and Biomedical Engineering who helped develop the scanner.

The UCL team say more work is needed with a larger group of patients to demonstrate the potential of the technology before it is ready to be developed into a device for routine use in clinics.

This post appeared first on sky.com

0
FacebookTwitterGoogle +Pinterest
previous post
Strong Preliminary Feasibility for Bécancour Lithium Refinery
next post
France’s Le Pen and her party go on trial accused of embezzling EU funds

You may also like

NHS shingles vaccine targeting herpes zoster virus could...

July 26, 2024

‘Year’s best meteor shower’ and the moon’s ‘whistle-stop...

July 13, 2024

The Data Use and Access Bill: How new...

October 24, 2024

Sky Mobile down – with users experiencing internet...

April 11, 2024

Lung cancer patient is first in UK to...

August 23, 2024

Pavel Durov: Russia calls Telegram founder a ‘political...

August 26, 2024

How will two astronauts stuck in space pass...

August 11, 2024

Mobile phone use doesn’t increase brain cancer risk,...

September 4, 2024

Chinese researchers use DNA to reconstruct Emperor Wu’s...

April 4, 2024

Trillions of cicadas to emerge across US ‘in...

April 4, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Tartana Drilling to Verify Upgrading of 45,000 Tonne Copper Resource

    • 2

      Magic mushrooms effective for treating depression – study

    • 3

      Lancaster Resources Welcomes Three Highly Experienced Industry Experts to Its Advisory Board

    • 4

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s more proof the city is moving closer to China

    • 5

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    Categories

    • Business (1,129)
    • Investing (2,670)
    • Science (605)
    • World (3,241)
    Footer Logo

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 dailywashingtoninsider.com | All Rights Reserved